Hazard
1,417 recalls in our database tag this hazard, drawn from FDA, USDA FSIS, CPSC, and NHTSA source notices.
Of the 1,417 lack of sterility recalls we have scored against our rubric, 3 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1,048 (74%) are Severe.
Which agencies issued them
Hazard tags are short, machine-readable labels we attach to every recall to make cross-cutting queries possible — “all lack of sterility recalls regardless of agency”, “all listeria recalls in California”, “all airbag recalls in 2025”. The tags are extracted from each recall’s source text during the LLM rewrite step and validated against a fixed schema.
A recall can carry multiple tags — a Listeria recall might also be tagged ready-to-eat and undeclared-allergen. Use the full-text search if you want to combine hazard tags with brand or category filters.
Perry Drug Inc. is recalling HCG Low Dose vials in Kansas and Missouri due to quality control issues affecting sterility assurance.
Perry Drug Inc. is recalling compounded HCG injections in Kansas and Missouri due to potential sterility assurance issues identified during an FDA inspection.
Perry Drug Inc. is recalling compounded Testosterone CYP-250/PROP-20 mg syringes in Kansas and Missouri due to quality control issues affecting sterility assurance.
Perry Drug Inc. is recalling HCG injections due to quality control issues that may compromise sterility assurance.
Oregon Compounding Centers is recalling injectable ascorbic acid vials because quality control issues observed during an FDA inspection present a potential risk to sterility assurance.
Oregon Compounding Centers is recalling Bevacizumab/Dexamethasone injectable syringes due to quality control issues affecting sterility assurance identified during an FDA inspection.
Specialty Compounding, LLC is recalling all prescription products manufactured by the company due to a lack of assurance of sterility.
Martin Avenue Pharmacy is voluntarily recalling Tri-mix T105 injectable vials due to quality control observations that present a risk to sterility assurance.
New England Home Therapies is recalling all sterile drugs compounded between February 21 and 24, 2014, due to a lack of assurance of sterility.
Pioneer Surgical Technology is recalling 5 units of the Tritium Sternal Plate System in Texas and Florida due to a lack of sterility assurance.
John W Hollis Inc is recalling 80 mL vials of Lipotropic Gold injectable products because they may lack sterility assurance.
John W Hollis Inc. is recalling Levocarnitine Solution for injection because the company cannot ensure the product is sterile. The recall covers specific lots distributed nationwide.
John W Hollis Inc is recalling Methylcobalamin 1000 mcg injectable products because they lack assurance of sterility. The recall covers Lot # 1862 distributed nationwide.
John W Hollis Inc. is recalling Lot 2868 of Polidocanol 1% Solution for Injection because the company cannot ensure the product is sterile.
Natures Pharmacy & Compounding Center is recalling all lots of Bladder Instillation due to quality control concerns affecting sterility assurance.
Natures Pharmacy & Compounding Center is recalling Papaverine 1nj 30mg/ml due to quality control concerns that present a potential risk to sterility assurance.
Natures Pharmacy & Compounding Center is recalling all lots of Estradiol Cypionate and Testosterone Cypionate due to sterility assurance concerns identified during an FDA inspection.
Natures Pharmacy & Compounding Center is recalling Cyano B-12 (Cmpd) 1000mcg/ml due to quality control issues affecting sterility assurance.
Natures Pharmacy & Compounding Center is recalling all lots of Dexamethasone phosphate 24mg/ml injection due to quality control concerns affecting sterility assurance.
Natures Pharmacy & Compounding Center is recalling all lots of Vancomycin (fortified) 25mg/ml ophthalmic solution due to quality control issues affecting sterility assurance.
Specialty Medicine Compounding Pharmacy is recalling Phenol, 6%, Injectable, because sterility cannot be assured after a related product was found non-sterile.
Specialty Medicine Compounding Pharmacy is recalling repackaged Gatifloxacin ophthalmic drops because sterility cannot be assured due to shared compounding practices with a non-sterile product.
Specialty Medicine Compounding Pharmacy is recalling Cyclopentolate HCL ophthalmic products because sterility cannot be assured after a related product was found non-sterile.
Specialty Medicine Compounding Pharmacy is recalling Hydroxyprogesterone 17alpha-PF 250 mg/mL injectable because sterility cannot be assured after a related product was found non-sterile.
Specialty Medicine Compounding Pharmacy is recalling Quad Mix injectable products because sterility cannot be assured after a related product was found non-sterile.